CAR-T Cell Therapy: From the Shop to Cancer Therapy
International Journal of Molecular Sciences · 28.10.2023 · 24 (21) · 15688
DOI: 10.3390/ijms242115688 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.10.2023. Verfasst von Ashanti Concepción Uscanga-Palomeque und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66450, Nuevo Le…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Neoplasms. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer is a worldwide health problem. Nevertheless, new technologies in the immunotherapy field have emerged. Chimeric antigen receptor (CAR) technology is a novel biological form to treat cancer; CAR-T cell genetic engineering has positively revolutionized cancer immunotherapy. In this paper, we review the latest developments in CAR-T in cancer treatment. We present the structure of the different generations and variants of CAR-T cells including TRUCK (T cells redirected for universal cytokine killing. We explain the approaches of the CAR-T cells manufactured ex vivo and in vivo. Moreover, we describe the limitations and areas of opportunity for this immunotherapy and the current challenges of treating hematological and solid cancer using CAR-T technology as well as its constraints and engineering approaches. We summarize other immune cells that have been using CAR technology, such as natural killer (NK), macrophages (M), and dendritic cells (DC). We conclude that CAR-T cells have the potential to treat not only cancer but other chronic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66450, Nuevo León, Mexico.
ORCID-Profile: Ashanti Concepción Uscanga-Palomeque, Cristina Rodríguez-Padilla, Juan Manuel Alcocer-González
Zitieren
APA
Uscanga-Palomeque, A. C., Chávez-Escamilla, A. K., Alvizo-Báez, C. A., Saavedra-Alonso, S., Terrazas-Armendáriz, L. D., Tamez-Guerra, R. S., Rodríguez-Padilla, C., & Alcocer-González, J. M. (2023). CAR-T Cell Therapy: From the Shop to Cancer Therapy. International Journal of Molecular Sciences, 24(21), 15688. https://doi.org/10.3390/ijms242115688
Vancouver
Uscanga-Palomeque AC, Chávez-Escamilla AK, Alvizo-Báez CA, Saavedra-Alonso S, Terrazas-Armendáriz LD, Tamez-Guerra RS, et al. CAR-T Cell Therapy: From the Shop to Cancer Therapy. International Journal of Molecular Sciences. 2023;24(21):15688. doi:10.3390/ijms242115688
BibTeX
@article{UscangaPalomeque2023,
author = {Uscanga-Palomeque, Ashanti Concepción and Chávez-Escamilla, Ana Karina and Alvizo-Báez, Cynthia Aracely and Saavedra-Alonso, Santiago and Terrazas-Armendáriz, Luis Daniel and Tamez-Guerra, Reyes S and Rodríguez-Padilla, Cristina and Alcocer-González, Juan Manuel},
title = {CAR-T Cell Therapy: From the Shop to Cancer Therapy},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {21},
pages = {15688},
doi = {10.3390/ijms242115688}
}
EUVIMED